Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE4A | P27815 | 2/20 | 0.34 |
| ▸ | PDE4B | Q07343 | 2/20 | 0.34 |
| ▸ | PDE4C | Q08493 | 2/20 | 0.34 |
| ▸ | PDE4D | Q08499 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.32 |
| ▸ | CA2 | P00918 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | POLL | Q9UGP5 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.31 |
| ▸ | USP2 | O75604 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16179964 | 0.70 | CA1 (0.32) | CA1CA2CA4KMT2A | |
| SCHEMBL28921787 | 0.68 | PDGFRB (0.31) | — | |
| SCHEMBL4077250 | 0.68 | KDM4E (0.31) | CA1CA2CA4POLB | |
| SCHEMBL59379 | 0.65 | KDM4E (0.37) | CA1CA2CA4KMT2AALDH1A1 | |
| SCHEMBL7642946 | 0.63 | CA1 (0.35) | CA1CA2CA4KMT2AALDH1A1 | |
| SCHEMBL11739358 | 0.62 | KDM4E (0.36) | CA1CA2CA4POLB | |
| SCHEMBL28614043 | 0.62 | KDM4E (0.36) | CA1CA2CA4POLB | |
| SCHEMBL7635786 | 0.62 | KMT2A (0.38) | CA1CA2CA4KMT2AALDH1A1 | |
| SCHEMBL7636295 | 0.62 | KMT2A (0.38) | CA1CA2CA4KMT2AALDH1A1 | |
| SCHEMBL7633674 | 0.62 | KMT2A (0.38) | CA1CA2CA4KMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9518076-B2 | Apparatus and process for preparing reactive lignin with high yield from plant biomass for production of fuels and chemicals | WASHINGTON STATE UNIVERSITY (US) | 2016-12-13 | — | — | US | disclosed |
| US-20150099868-A1 | APPARATUS AND PROCESS FOR PREPARING REACTIVE LIGNIN WITH HIGH YIELD FROM PLANT BIOMASS FOR PRODUCTION OF FUELS AND CHEMICALS | WASHINGTON STATE UNIVERSITY (US) | 2015-04-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099868-A1 | APPARATUS AND PROCESS FOR PREPARING REACTIVE LIGNIN WITH HIGH YIELD FROM PLANT BIOMASS FOR PRODUCTION OF FUELS AND CHEMICALS | HAAO, HAO2, HAO1 | PDE4A 2905/4885PDE4B 2633/4885PDE4C 3261/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.